What metrics would you use to evaluate Evidation Health's data collection platform for clinical trials?

Introduction

Evaluating Evidation Health's data collection platform for clinical trials requires a comprehensive approach to product success metrics. This platform plays a crucial role in the healthcare technology ecosystem, bridging the gap between patients, researchers, and pharmaceutical companies. To effectively assess its performance, we'll follow a structured framework that covers core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Evidation Health's data collection platform is a digital health solution designed to facilitate the collection of real-world data for clinical trials. It leverages mobile devices and wearables to gather patient-generated health data (PGHD) continuously, providing researchers with a more comprehensive and longitudinal view of participants' health status.

Key stakeholders include:

1. Clinical trial participants: Motivated by contributing to medical research and potentially accessing new treatments.
2. Pharmaceutical companies: Seeking high-quality, real-world data to support drug development and regulatory submissions.
3. Researchers: Aiming for robust, diverse datasets to enhance study validity and accelerate discoveries.
4. Healthcare providers: Interested in insights that could improve patient care.

User flow:

1. Onboarding: Participants download the app, consent to data sharing, and connect their devices.
2. Data collection: The platform passively collects data from wearables and prompts users for additional inputs.
3. Engagement: Users receive updates on study progress and may be asked to complete specific tasks or surveys.
4. Data analysis: Researchers access anonymized data through a secure portal for analysis.

This platform aligns with Evidation Health's broader strategy of democratizing access to health data and accelerating clinical research. Compared to traditional data collection methods, it offers real-time, continuous data capture with reduced participant burden.

In terms of product lifecycle, the platform is in the growth stage, with increasing adoption among pharmaceutical companies and researchers, but still facing challenges in scaling and standardization across diverse study types.